Last reviewed · How we verify
"drug holidays" (D)
Drug holidays involve temporarily stopping or reducing the dosage of a medication to allow the body to recover from side effects.
Drug holidays involve temporarily stopping or reducing the dosage of a medication to allow the body to recover from side effects. Used for Managing side effects in patients with chronic conditions, Improving quality of life in patients with long-term medication regimens.
At a glance
| Generic name | "drug holidays" (D) |
|---|---|
| Sponsor | Stefan Lakämper |
| Drug class | Medication holiday |
| Modality | Small molecule |
| Therapeutic area | Oncology, Cardiology |
| Phase | FDA-approved |
Mechanism of action
This approach can help manage side effects, improve quality of life, and potentially reduce the risk of long-term complications. However, it requires careful planning and monitoring to ensure the medication remains effective and safe.
Approved indications
- Managing side effects in patients with chronic conditions
- Improving quality of life in patients with long-term medication regimens
Common side effects
- Rebound effect
- Increased risk of disease progression
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- "drug holidays" (D) CI brief — competitive landscape report
- "drug holidays" (D) updates RSS · CI watch RSS
- Stefan Lakämper portfolio CI